Latest Cancer immunotherapy Stories
Researchers at Northwestern University have announced a cancer-treatment breakthrough based on three decades of work.
SOUTH SAN FRANCISCO, Calif., March 2, 2015 /PRNewswire/ -- CytomX, a biotechnology company developing Probody(TM) therapeutics for the treatment of cancer, today announced the creation of
NEW YORK, Feb.
LAKE FOREST, Calif., Feb. 24, 2015 /PRNewswire/ -- Cryoport, Inc.
Move puts company in ideal position to attract top scientific and medical talent to advance OncoVAX® clinical trial BALTIMORE, Feb.
LOS ANGELES, Feb. 18, 2015 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) today announced the appointment of Steven J.
Selective RORgamma agonist product candidates demonstrated activity as single agent therapy NEW YORK and ANN ARBOR, Mich., Feb.
Proceeds will Fund ACTIVE: the Phase IIIb OncoVAX® Trial and Company Expansion FREDERICK, Md., Jan.
SITC-Merck Cancer Immunotherapy Clinical Fellowship Award to Grant Young Investigator $100,000 to Advance the Field Milwaukee, WI (PRWEB) January 26, 2015
- Small missiles, especially grape, canister, fragments of iron, and the like, when fired, as upon an enemy at close quarters.
- To fire mitraille at.